Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Most patients improved with oral contraceptives, but some needed additional treatment.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Acne and other skin conditions can indicate internal diseases like Polycystic Ovary Syndrome (PCOS), and early treatment can prevent long-term issues.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

PCOS is a common hormonal disorder in women, causing symptoms like acne and irregular periods, and is managed with medication and lifestyle changes.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

CT scans can find serious prostate cancer even when PSA levels are low.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

The Gas-Antisolvent process can be effectively modeled and optimized to create Finasteride, a hair growth drug.

A method was found to accurately measure spironolactone and canrenone in blood samples using liquid chromatography-mass spectrometry.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The new gel for hair loss is safe, effective, and reduces side effects.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.